Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Efficacy of Cobolimab, Dostarlimab, and Docetaxel in Advanced Non-Small Cell Lung Cancer Post Anti-PD(L)1 Therapy and Chemotherapy

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    Belgium Finland France Germany Greece Italy +5
  • A study to evaluate how the body processes zipalertinib in healthy adult men

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • A study to evaluate how lazertinib is absorbed in healthy adults to support future treatment for non-small cell lung cancer.

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium
  • A Study of CLDN6 CAR-T Cell Therapy With or Without CLDN6 RNA-LPX Vaccine in Patients With CLDN6-Positive Advanced Solid Tumors That Returned or Did Not Respond to Treatment

    Not recruiting

    1 1 1
    Germany The Netherlands Sweden
  • Study of romiplostim for treating low platelet counts caused by chemotherapy in adults with non-small cell lung cancer, ovarian cancer, or breast cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    Greece Poland Portugal Romania Spain
  • Study comparing how the body processes GB1211 capsule and tablet forms with and without food in healthy volunteers

    Not recruiting

    1 1 1
    The Netherlands
  • Study of zoldonrasib in patients with RAS G12D mutation non-small cell lung cancer who have received previous treatment

    Not recruiting

    2 1 1
    Austria Czechia Denmark France Germany Greece +3
  • Study of AMG 193 tablets for patients with advanced non-small cell lung cancer (NSCLC) who have previously received treatment and have MTAP gene deletion

    Not recruiting

    2 1 1
    Investigated Drugs:
    Belgium Czechia France Germany Greece Hungary +6
  • Study of alectinib, pemetrexed, carboplatin and cisplatin in patients with resectable stage I-III non-small cell lung cancer

    Not recruiting

    2 1 1 1
    Austria Belgium Denmark France Italy The Netherlands +2
  • Study on the Safety and Effectiveness of AZD0022 Alone and with Other Cancer Drugs for Adults with KRAS-G12D Mutated Tumors in Lung, Colorectal, and Pancreatic Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Belgium Italy The Netherlands Poland Spain